New drug cocktail aims to outsmart relapsed leukemia
Disease control
Recruiting now
This early-phase trial is testing whether adding ruxolitinib to the standard drugs azacitidine and venetoclax is safe for people with acute myeloid leukemia (AML) that has come back or not responded to treatment. About 51 adults will receive the three-drug combination to find the…
Phase: PHASE1 • Sponsor: Jennifer Saultz • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC